Woolson Daniel Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
6
Insider Sells Sum
$1.82M

Insider Activity of Woolson Daniel

According to the SEC Form 4 filings, Woolson Daniel, being in a position of

  1. VP, GM-Infusion Capital at ICU Medical, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 10437 shares for $1.7M,
    over all time since 2018-05-24, has bought 0 shares, and sold 21194 shares for $3.52M.

Biography of Woolson Daniel

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,704,3143100

Comparison of Insiders on Amount of Buys and Sells

2026-08-13SaleICU Medical, Inc.
ICUI
VP, GM-Infusion Capital
5,417
0.0215%
$181.33$982,265-10.81%
2026-05-22SaleICU Medical, Inc.
ICUI
President
2,123
0.0086%
$132.21$280,685+20.65%
2025-11-25SaleICU Medical, Inc.
ICUI
VP, GM-Infusion Capital
2,897
0.0126%
$152.35$441,364-1.73%
2024-12-06SaleICU Medical, Inc.
ICUI
VP, GM-Infusion Capital
2,241
0.0092%
$156.25$350,158-12.89%
2024-08-30SaleICU Medical, Inc.
ICUI
VP, GM-Infusion Capital
2,502
0.0101%
$163.22$408,370-9.38%
2024-03-15SaleICU Medical, Inc.
ICUI
VP, GM-Infusion Capital
791
0.0033%
$98.27$77,733+58.21%
2023-12-01SaleICU Medical, Inc.
ICUI
VP, GM-Infusion Capital
1,729
0.0069%
$88.03$152,196+19.12%
2023-02-02SaleICU Medical, Inc.
ICUI
VP, GM-Infusion Capital
1,731
0.0073%
$200.00$346,200-22.51%
2018-05-24SaleICU Medical, Inc.
ICUI
VP, GM-Infusion Capital
1,763
0.0087%
$273.67$482,480-8.3%
Total: 9
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.